<?properties open_access?>
<?DTDIdentifier.IdentifierValue -//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.1 20151215//EN?>
<?DTDIdentifier.IdentifierType public?>
<?SourceDTD.DTDName JATS-journalpublishing1.dtd?>
<?SourceDTD.Version 1.1?>
<?ConverterInfo.XSLTName jp2nlmx2.xsl?>
<?ConverterInfo.Version 1?>
<front>
  <journal-meta>
    <journal-id journal-id-type="nlm-ta">Database (Oxford)</journal-id>
    <journal-id journal-id-type="iso-abbrev">Database (Oxford)</journal-id>
    <journal-id journal-id-type="publisher-id">databa</journal-id>
    <journal-title-group>
      <journal-title>Database: The Journal of Biological Databases and Curation</journal-title>
    </journal-title-group>
    <issn pub-type="epub">1758-0463</issn>
    <publisher>
      <publisher-name>Oxford University Press</publisher-name>
    </publisher>
  </journal-meta>
  <article-meta>
    <article-id pub-id-type="pmcid">7402919</article-id>
    <article-id pub-id-type="pmid">32754758</article-id>
    <article-id pub-id-type="doi">10.1093/database/baaa058</article-id>
    <article-id pub-id-type="publisher-id">baaa058</article-id>
    <article-categories>
      <subj-group subj-group-type="category-taxonomy-collection">
        <subject>AcademicSubjects/SCI00960</subject>
      </subj-group>
      <subj-group subj-group-type="heading">
        <subject>Original Article</subject>
      </subj-group>
    </article-categories>
    <title-group>
      <article-title>ConoMode, a database for conopeptide binding modes</article-title>
    </title-group>
    <contrib-group>
      <contrib contrib-type="author">
        <name>
          <surname>Li</surname>
          <given-names>Xiao</given-names>
        </name>
        <xref ref-type="aff" rid="aff1">1</xref>
        <xref ref-type="aff" rid="aff3">3</xref>
        <xref ref-type="author-notes" rid="afn1"/>
      </contrib>
      <contrib contrib-type="author">
        <name>
          <surname>Liu</surname>
          <given-names>Hao</given-names>
        </name>
        <xref ref-type="aff" rid="aff2">2</xref>
        <xref ref-type="aff" rid="aff3">3</xref>
        <xref ref-type="author-notes" rid="afn1"/>
      </contrib>
      <contrib contrib-type="author">
        <name>
          <surname>Gao</surname>
          <given-names>Chunxiao</given-names>
        </name>
        <xref ref-type="aff" rid="aff2">2</xref>
        <xref ref-type="aff" rid="aff3">3</xref>
      </contrib>
      <contrib contrib-type="author">
        <name>
          <surname>Li</surname>
          <given-names>Yangyang</given-names>
        </name>
        <xref ref-type="aff" rid="aff2">2</xref>
        <xref ref-type="aff" rid="aff3">3</xref>
      </contrib>
      <contrib contrib-type="author">
        <name>
          <surname>Jia</surname>
          <given-names>Dongning</given-names>
        </name>
        <xref ref-type="aff" rid="aff2">2</xref>
        <xref ref-type="aff" rid="aff3">3</xref>
      </contrib>
      <contrib contrib-type="author">
        <name>
          <surname>Yang</surname>
          <given-names>Yanbo</given-names>
        </name>
        <xref ref-type="aff" rid="aff2">2</xref>
        <xref ref-type="aff" rid="aff3">3</xref>
      </contrib>
      <contrib contrib-type="author">
        <name>
          <surname>Yang</surname>
          <given-names>Jinbo</given-names>
        </name>
        <xref ref-type="aff" rid="aff1">1</xref>
        <xref ref-type="aff" rid="aff3">3</xref>
      </contrib>
      <contrib contrib-type="author">
        <name>
          <surname>Wei</surname>
          <given-names>Zhiqiang</given-names>
        </name>
        <xref ref-type="aff" rid="aff2">2</xref>
        <xref ref-type="aff" rid="aff3">3</xref>
      </contrib>
      <contrib contrib-type="author">
        <name>
          <surname>Jiang</surname>
          <given-names>Tao</given-names>
        </name>
        <xref ref-type="aff" rid="aff1">1</xref>
        <xref ref-type="aff" rid="aff3">3</xref>
      </contrib>
      <contrib contrib-type="author">
        <name>
          <surname>Yu</surname>
          <given-names>Rilei</given-names>
        </name>
        <xref ref-type="aff" rid="aff1">1</xref>
        <xref ref-type="aff" rid="aff3">3</xref>
        <!--<email>ryu@ouc.edu.cn</email>-->
        <xref rid="cor1" ref-type="corresp"/>
      </contrib>
    </contrib-group>
    <aff id="aff1"><label>1</label>Key Laboratory of Marine Drugs, Chinese Ministry of Education, School of Medicine and Pharmacy, <institution>Ocean University of China</institution>, Qingdao 266003, <country country="CN">China</country></aff>
    <aff id="aff2"><label>2</label>Department of Computer Science and Technology, <institution>Ocean University of China</institution>, Qingdao 266100, <country country="CN">China</country></aff>
    <aff id="aff3"><label>3</label><institution>Qingdao National Laboratory for Marine Science and Technology</institution>, Qingdao 266003, <country country="CN">China</country></aff>
    <author-notes>
      <corresp id="cor1">Corresponding author: Tel: +86-1386-986-2306; Email: <email>ryu@ouc.edu.cn</email></corresp>
      <fn id="afn1">
        <p>Xiao Li and Hao Liu These authors contributed equally to this work.</p>
      </fn>
    </author-notes>
    <pub-date pub-type="collection">
      <year>2020</year>
    </pub-date>
    <pub-date pub-type="epub" iso-8601-date="2020-08-04">
      <day>04</day>
      <month>8</month>
      <year>2020</year>
    </pub-date>
    <pub-date pub-type="pmc-release">
      <day>04</day>
      <month>8</month>
      <year>2020</year>
    </pub-date>
    <!-- PMC Release delay is 0 months and 0 days and was based on the <pub-date pub-type="epub"/>. -->
    <volume>2020</volume>
    <elocation-id>baaa058</elocation-id>
    <history>
      <date date-type="received">
        <day>14</day>
        <month>3</month>
        <year>2020</year>
      </date>
      <date date-type="rev-recd">
        <day>23</day>
        <month>6</month>
        <year>2020</year>
      </date>
      <date date-type="accepted">
        <day>7</day>
        <month>7</month>
        <year>2020</year>
      </date>
    </history>
    <permissions>
      <copyright-statement>Â© The Author(s) 2020. Published by Oxford University Press.</copyright-statement>
      <copyright-year>2020</copyright-year>
      <license license-type="cc-by" xlink:href="http://creativecommons.org/licenses/by/4.0/">
        <license-p>This is an Open Access article distributed under the terms of the Creative Commons Attribution License (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">http://creativecommons.org/licenses/by/4.0/</ext-link>), which permits unrestricted reuse, distribution, and reproduction in any medium, provided the original work is properly cited.</license-p>
      </license>
    </permissions>
    <self-uri xlink:href="baaa058.pdf"/>
    <abstract>
      <title>Abstract</title>
      <p>ConoMode is a database for complex three-dimensional (3D) structures of conopeptides binding with their target proteins. Conopeptides, a large family of peptides from the venom of marine snails of the <italic>Conus</italic> genus, have exceptionally diverse sequences, and their high specificity to block ion channels makes them crucial as drug leads and tools for physiological studies. ConoMode is a specialized archive for the collection of 3D coordinate data for the conopeptides and their binding target proteins from published literature and the Protein Data Bank. These 3D structures can be determined using experimental methods such as X-ray crystallography and electron microscopy and computational methods including docking, homology modeling and molecular dynamics simulations. The binding modes for the conopeptides determined using computational modeling must be validated based on experimental data. The 3D coordinate data from ConoMode can be searched, visualized, downloaded and uploaded. Currently, ConoMode manages 19 conopeptide sequences (from 10 <italic>Conus</italic> species), 15 protein sequences and 37 3D structures. ConoMode utilizes a modern technical framework to provide a good user experience on mobile devices with touch interaction features. Furthermore, the database is fully optimized for unstructured data and flexible data models.</p>
      <p><bold>Database URL</bold>: <ext-link ext-link-type="uri" xlink:href="http://conomode.qnlm.ac/conomode/conomode/index">http://conomode.qnlm.ac/conomode/conomode/index</ext-link></p>
    </abstract>
    <funding-group>
      <award-group award-type="grant">
        <funding-source>
          <institution-wrap>
            <institution content-type="funder-name">Major Scientific Research Platform Construction Project of Shandong Province</institution>
          </institution-wrap>
        </funding-source>
        <award-id>2018SDPT01</award-id>
      </award-group>
      <award-group award-type="grant">
        <funding-source>
          <institution-wrap>
            <institution content-type="funder-name">Marine S&amp;T Fund of Shandong Province for Pilot National Laboratory for Marine Science and Technology</institution>
          </institution-wrap>
        </funding-source>
        <award-id>2018SDKJ0402</award-id>
      </award-group>
      <award-group award-type="grant">
        <funding-source>
          <institution-wrap>
            <institution content-type="funder-name">Fundamental Research Funds for the Central Universities</institution>
            <institution-id institution-id-type="DOI">10.13039/501100012226</institution-id>
          </institution-wrap>
        </funding-source>
        <award-id>201941012</award-id>
        <award-id>201762011</award-id>
      </award-group>
      <award-group award-type="grant">
        <funding-source>
          <institution-wrap>
            <institution content-type="funder-name">National Laboratory Director Fund</institution>
          </institution-wrap>
        </funding-source>
        <award-id>QNLM201709</award-id>
      </award-group>
      <award-group award-type="grant">
        <funding-source>
          <institution-wrap>
            <institution content-type="funder-name">National Science and Technology Major Project for Significant New Drugs Development</institution>
          </institution-wrap>
        </funding-source>
        <award-id>2018ZX09735004</award-id>
      </award-group>
      <award-group award-type="grant">
        <funding-source>
          <institution-wrap>
            <institution content-type="funder-name">National Key Research and Development Program of China</institution>
            <institution-id institution-id-type="DOI">10.13039/501100012166</institution-id>
          </institution-wrap>
        </funding-source>
        <award-id>2019YFC0312601</award-id>
      </award-group>
    </funding-group>
    <counts>
      <page-count count="5"/>
    </counts>
  </article-meta>
</front>
<body>
  <sec id="sec1">
    <title>Introduction</title>
    <p>Conotoxins are cocktail-like mixtures derived from the venom of marine predatory cone snails, which contains more than 100 types of bioactive peptides (<xref rid="ref1" ref-type="bibr">1</xref>, <xref rid="ref2" ref-type="bibr">2</xref>). It is estimated that ~1â000â000 conotoxins exist among different <italic>Conus</italic> species (<xref rid="ref3" ref-type="bibr">3</xref>), and they can be categorized according to the cysteine framework, gene superfamily and pharmacological family (<xref rid="ref2" ref-type="bibr">2</xref>, <xref rid="ref4" ref-type="bibr">4</xref>). The majority of conotoxins range in sequence length from 10 to 40 amino acids (<xref rid="ref4" ref-type="bibr">4</xref>), and their highly conserved disulfide linkages, backbones and diverse chemical structures enable their excellent potency and specificity for various targets, including nicotinic acetylcholine receptors (nAChRs), ion channels (sodium, calcium, potassium), G-protein coupled receptors and enzymes (<xref rid="ref5" ref-type="bibr">5</xref>, <xref rid="ref6" ref-type="bibr">6</xref>). Conotoxins have remarkable potential for therapeutics, making them valuable as pharmacological tools and peptide drug leads. Ï-Conotoxin MVIIA, also known as ziconotide, was approved by the U.S. Food and Drug Administration as an effective analgesic drug to treat chronic nociceptive and neuropathic pain of malignant and nonmalignant origin (<xref rid="ref7" ref-type="bibr">7</xref>). The identification of interactions between conotoxins and their targets will substantially facilitate the development of new drugs.</p>
    <fig id="f1" orientation="portrait" position="float">
      <label>Figure 1.</label>
      <caption>
        <p>Structure and function of the ConoMode webserver.</p>
      </caption>
      <graphic xlink:href="baaa058f1"/>
    </fig>
    <fig id="f2" orientation="portrait" position="float">
      <label>Figure 2.</label>
      <caption>
        <p>Screenshot of ConoMode website. (<bold>a</bold>) Interface of the ConoMode database. (<bold>b</bold>) Detailed page of Vc1.1-Î±9Î±9.</p>
      </caption>
      <graphic xlink:href="baaa058f2"/>
    </fig>
    <p>Î±-Conotoxins, a major conotoxin family, are typical antagonists of nAChRs (<xref rid="ref6" ref-type="bibr">6</xref>, <xref rid="ref8" ref-type="bibr">8</xref>). nAChRs function as ligand-gated ion channels, which are generally responsible for synaptic transmission in the nervous system or other nonneural cells in different physiological events (<xref rid="ref6" ref-type="bibr">6</xref>, <xref rid="ref8" ref-type="bibr">8</xref>, <xref rid="ref9" ref-type="bibr">9</xref>). nAChRs can be inhibited by conotoxins, producing analgesic effects in inflammatory pain and hyperalgesia neuropathic pain models (<xref rid="ref9" ref-type="bibr">9</xref>). Crystal structures of the acetylcholine binding protein (AChBP), a homolog of the nAChR extracellular domain, have been used as surrogate or homology modeling templates to study the interactions between conotoxins and nAChRs (<xref rid="ref10" ref-type="bibr">10â17</xref>).</p>
    <p>Another large pharmacological class of conotoxins are Î¼-conotoxins, which exhibit high potency and specificity on voltage-gated sodium channels (Navs) (<xref rid="ref18" ref-type="bibr">18â22</xref>). Navs initiate action potentials in neurons and other excitable cells, and their dysfunction causes inherited epilepsy, chronic pain and other diseases of hyperexcitability (<xref rid="ref18" ref-type="bibr">18</xref>). Since sodium channels play a key role in generating and propagating action potential, they represent a class of appealing targets for drug development in the treatment of neuropathic pain (<xref rid="ref10" ref-type="bibr">10</xref>, <xref rid="ref18" ref-type="bibr">18</xref>). Recently, crystal structures of prokaryotic Navs, such as those from <italic>Arcobacter butzleri</italic> (NavAb) and <italic>Magnetococcus marinus</italic> (NavMs) (<xref rid="ref20" ref-type="bibr">20</xref>, <xref rid="ref22" ref-type="bibr">22</xref>), have also been used extensively as templates for the homology modeling of eukaryotic Navs interacting with Î¼-conotoxins (<xref rid="ref21" ref-type="bibr">21</xref>, <xref rid="ref22" ref-type="bibr">22</xref>).</p>
    <p>Owing to their potential druggability and lower cellular toxicity compared to that of small-molecule drugs, conotoxins are receiving increasing attention based on their development as drug leads (<xref rid="ref1" ref-type="bibr">1</xref>, <xref rid="ref9" ref-type="bibr">9</xref>). Different chemical modification strategies have been used to enhance the potency, specificity and stability of conotoxins (<xref rid="ref1" ref-type="bibr">1</xref>). However, the structure-activity relationship of conotoxins interacting with ion channels is poorly understood because of the lack of high-resolution complex structures between conotoxins and their targets. Determination of ion channel crystal structures remains a challenge, whereas crystal structures of their homologs, such as AChBP and NavAb or NavMs are relatively easy to determine.</p>
    <p>Recent advancements in cryo-electron microscopy (cryo-EM) technology have made it possible to resolve the relatively high-resolution structure of ion channels, such as nAChR, eukaryotic Nav and voltage-gated calcium channels (<xref rid="ref23" ref-type="bibr">23â27</xref>). The appearances of these structures significantly increased the accuracy of computationally modeling the interactions between these ion channels and their targeting conotoxins (<xref rid="ref29" ref-type="bibr">29â32</xref>). To date, only a few conotoxin-bound ion channel structures are present in the Protein Data Bank (PDB) (<xref rid="ref23" ref-type="bibr">23</xref>, <xref rid="ref28" ref-type="bibr">28</xref>). Thus, computational modeling of the interactions between conotoxins and their targeting receptors will continue to be the most efficient approach for understanding the structure-activity relationship of conotoxins at the molecular level (<xref rid="ref29" ref-type="bibr">29</xref>, <xref rid="ref30" ref-type="bibr">30</xref>).</p>
    <p>Accurate determination of the binding modes of conotoxins to their targeting ion channels or receptors is essential for understanding their structure-activity relationship as well as for efficiently enhancing their activity, specificity or stability (<xref rid="ref2" ref-type="bibr">2</xref>). Recently, more than 50 computational models between conotoxins and their targeting ion channels were published, among which more than 20 were published by Yu <italic>etÂ al</italic>. (<xref rid="ref33" ref-type="bibr">33â40</xref>). Most of these models were supported by their ability to explain results from mutagenesis studies. These models could be used to interpret experimental results or even as guidance for structure optimization of these conotoxins. However, these complex structures are not accepted by the PDB database, in which only structures determined based on crystallography, cryo-EM or nuclear magnetic resonance (NMR) are accepted for deposition (<xref rid="ref23" ref-type="bibr">23</xref>, <xref rid="ref28" ref-type="bibr">28</xref>). Thus, a database for specifically managing giving access to these published conotoxin/ion channel structures would be helpful to the community working on peptide toxins. ConoMode is a database that specifically collects the binding complexes between conotoxins and their targets generated from computational modeling or determined based on experimental approaches, and a specialized administrator is responsible for regular updates and management at the Pilot National Laboratory of Marine Science and Technology (Qingdao). Users can freely download existing complexes or upload new complexes, which will significantly contribute to research on the conotoxin mechanism of action.</p>
  </sec>
  <sec id="sec2">
    <title>Materials and Methods</title>
    <sec id="sec3">
      <title>Data collections</title>
      <p>Currently, a total of 37 modes of binding between conotoxins and nAChRs or ion channels are exhibited on the ConoMode website. Among them, 28 were derived from our previously published studies in recent years (<xref rid="ref33" ref-type="bibr">33â40</xref>). These 28 structures were determined using computational modeling strategies, including homology modeling, docking and molecular dynamics simulations and the other 9 were derived from crystal complex structures obtained from the PDB (IDs: 4EZ1, 5CO5, 2C9T, 5XGL, 5JME, 2BR8, 2UZ6, 2BYP, 5T90, 6J8E) (<xref rid="ref10" ref-type="bibr">10â17</xref>, <xref rid="ref23" ref-type="bibr">23</xref>, <xref rid="ref28" ref-type="bibr">28</xref>).</p>
    </sec>
    <sec id="sec4">
      <title>Database architecture and web interface</title>
      <p>To support the search for a complex structure and for such an uncertain data model, the technical framework of the ConoMode webserver uses a typical SSM (Spring + SpringMVC + MyBatis) architecture (<xref rid="f1" ref-type="fig">Figure 1</xref>). The webserver utilizes schema-free technology to store data, and the model of the data entity can be flexibly changed according to requirements. Furthermore, ConoMode is optimized for unstructured data, especially conotoxin structures, and all file information content is dynamically generated by the database in the system.</p>
    </sec>
  </sec>
  <sec id="sec5">
    <title>Raw data uploading process</title>
    <p>The ConoMode database will be enriched by collecting the published complex structures of conotoxins/ion channels or receptors determined based on experimental approaches or calculated via computational modeling.</p>
    <p>Registered users can submit details of a complex structure between conotoxins and their targets. The uploading process requires three fundamental fields: the complex in PDB format, conotoxin sequence and target sequence. Users can provide source references and comments as extra fields. All successfully uploaded fields will be reviewed based on published experimental data. The evaluation consists of the data format and quality of the model. All accepted data will be deposited in the ConoMode database and will be displayed on the website.</p>
    <p>In ConoMode, each conotoxin complex is assigned a new ID according to the order in which it is uploaded. For instance, âC0001â represents the first complex uploaded on the website, and âCâ is the initial of âconotoxinâ.</p>
  </sec>
  <sec id="sec6">
    <title>Search and visualization</title>
    <p>Currently, ConoMode supports the conotoxin name, target name and conotoxin sequence as search keywords (<xref rid="f2" ref-type="fig">Figure 2</xref>). The results with brief information and link details are presented as a table. On the detailed page of each conotoxin, we provide download links for the complex, conotoxin sequence and target sequence. Information is divided into three parts on the webpage. The first part contains basic information on conotoxins, such as its name, sequence, organism species and original region (<xref rid="ref3" ref-type="bibr">3</xref>, <xref rid="ref4" ref-type="bibr">4</xref>). The second part consists of modeling approach, modeling templates and error approximation, the digital object identifier and the abstract of the references that the complex structure was determined was showed in the third part.</p>
    <p>Target names and IC<sub>50</sub> values constitute the major content of the third part. However, not every complex has exact IC<sub>50</sub> values, especially those with binding modes obtained from computational modeling; therefore, this information is not always available on the website.</p>
    <p>Considering that it is challenging to obtain the crystal structure of conotoxin complexes by experimental methods, ConoMode provides a special library for archiving conotoxin complexes determined by computational modeling. Users can not only use the models in ConoMode but also can share their published models with other researchers.</p>
  </sec>
  <sec id="sec7">
    <title>Discussion</title>
    <p>ConoMode is an unprecedented database that systematically collects complex structures of conotoxins and targets. Considering that it is challenging to obtain the crystal structure of a complex by experimental methods, ConoMode provides a special library of binding modes determined by homology modeling and molecular dynamics simulation for users to search, and users can also share their published models. Furthermore, interactions between conotoxins and their targets can be well predicted through these binding models, which makes ConoMode a powerful tool to promote research in this field.</p>
  </sec>
</body>
<back>
  <ack id="baaa058-ack">
    <title>Acknowledgments</title>
    <p>We thank Dr. Quentin Kaas, Institute for Molecular Bioscience, University of Queensland, Australia, for his valuable comments on a draft of the manuscript.</p>
  </ack>
  <sec id="sec8">
    <title>Funding</title>
    <p>National Key Research and Development Program of China (No. 2019YFC0312601), National Science and Technology Major Project for Significant New Drugs Development (No. 2018ZX09735004), the National Laboratory Director Fund (QNLM201709), the grant from the Fundamental Research Funds for the Central Universities (201762011 and 201941012) and the Marine S&amp;T Fund of Shandong Province for Pilot National Laboratory for Marine Science and Technology (Qingdao) (No. 2018SDKJ0402) and by the Major Scientific Research Platform Construction Project of Shandong Province (No. 2018SDPT01).</p>
  </sec>
  <ref-list id="bib1">
    <title>References</title>
    <ref id="ref1">
      <label>1.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Jin</surname><given-names>A.H.</given-names></name>, <name name-style="western"><surname>Muttenthaler</surname><given-names>M.</given-names></name>, <name name-style="western"><surname>Dutertre</surname><given-names>S.</given-names></name><etal>etÂ al.</etal></person-group> (<year>2019</year>) <article-title>Conotoxins: chemistry and biology</article-title>. <source>Chem. Rev.</source>, <volume>119</volume>, <fpage>11510</fpage>â<lpage>11549</lpage>.<pub-id pub-id-type="pmid">31633928</pub-id></mixed-citation>
    </ref>
    <ref id="ref2">
      <label>2.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Akondi</surname><given-names>K.B.</given-names></name>, <name name-style="western"><surname>Muttenthaler</surname><given-names>M.</given-names></name>, <name name-style="western"><surname>Dutertre</surname><given-names>S.</given-names></name><etal>etÂ al.</etal></person-group> (<year>2014</year>) <article-title>Discovery, synthesis, and structure-activity relationships of conotoxins</article-title>. <source>Chem. Rev.</source>, <volume>114</volume>, <fpage>5815</fpage>â<lpage>5847</lpage>.<pub-id pub-id-type="pmid">24720541</pub-id></mixed-citation>
    </ref>
    <ref id="ref3">
      <label>3.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kaas</surname><given-names>Q.</given-names></name>, <name name-style="western"><surname>Westermann</surname><given-names>J.C.</given-names></name>, <name name-style="western"><surname>Halai</surname><given-names>R.</given-names></name><etal>etÂ al.</etal></person-group> (<year>2008</year>) <article-title>ConoServer, a database for conopeptide sequences and structures</article-title>. <source>Bioinformatics</source>, <volume>24</volume>, <fpage>445</fpage>â<lpage>446</lpage>.<pub-id pub-id-type="pmid">18065428</pub-id></mixed-citation>
    </ref>
    <ref id="ref4">
      <label>4.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Mir</surname><given-names>R.</given-names></name>, <name name-style="western"><surname>Karim</surname><given-names>S.</given-names></name>, <name name-style="western"><surname>Kamal</surname><given-names>M.A.</given-names></name><etal>etÂ al.</etal></person-group> (<year>2016</year>) <article-title>Conotoxins: structure, therapeutic potential and pharmacological applications</article-title>. <source>Curr. Pharm. Des.</source>, <volume>22</volume>, <fpage>582</fpage>â<lpage>589</lpage>.<pub-id pub-id-type="pmid">26601961</pub-id></mixed-citation>
    </ref>
    <ref id="ref5">
      <label>5.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Zamponi</surname><given-names>G.W.</given-names></name></person-group> (<year>2016</year>) <article-title>Targeting voltage-gated calcium channels in neurological and psychiatric diseases</article-title>. <source>Nat. Rev. Drug Discov.</source>, <volume>15</volume>, <fpage>19</fpage>â<lpage>34</lpage>.<pub-id pub-id-type="pmid">26542451</pub-id></mixed-citation>
    </ref>
    <ref id="ref6">
      <label>6.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Abraham</surname><given-names>N.</given-names></name> and <name name-style="western"><surname>Lewis</surname><given-names>R.J.</given-names></name></person-group> (<year>2018</year>) <article-title>Neuronal nicotinic acetylcholine receptor modulators from cone snails</article-title>. <source>Mar. Drugs</source>, <volume>16</volume>, <fpage>pii: E208</fpage>.</mixed-citation>
    </ref>
    <ref id="ref7">
      <label>7.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Pope</surname><given-names>J.E.</given-names></name> and <name name-style="western"><surname>Deer</surname><given-names>T.R.</given-names></name></person-group> (<year>2013</year>) <article-title>Ziconotide: a clinical update and pharmacologic review</article-title>. <source>Expert Opin. Pharmacother.</source>, <volume>14</volume>, <fpage>957</fpage>â<lpage>966</lpage>.<pub-id pub-id-type="pmid">23537340</pub-id></mixed-citation>
    </ref>
    <ref id="ref8">
      <label>8.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Giribaldi</surname><given-names>J.</given-names></name> and <name name-style="western"><surname>Dutertre</surname><given-names>S.</given-names></name></person-group> (<year>2018</year>) <article-title>Î±-Conotoxins to explore the molecular, physiological and pathophysiological functions of neuronal nicotinic acetylcholine receptors</article-title>. <source>Neurosci. Lett.</source>, <volume>679</volume>, <fpage>24</fpage>â<lpage>34</lpage>.<pub-id pub-id-type="pmid">29199094</pub-id></mixed-citation>
    </ref>
    <ref id="ref9">
      <label>9.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Lewis</surname><given-names>R.J.</given-names></name>, <name name-style="western"><surname>Dutertre</surname><given-names>S.</given-names></name>, <name name-style="western"><surname>Vetter</surname><given-names>I.</given-names></name><etal>etÂ al.</etal></person-group> (<year>2012</year>) <article-title>Conus venom peptide pharmacology</article-title>. <source>Pharmacol. Rev.</source>, <volume>64</volume>, <fpage>259</fpage>â<lpage>298</lpage>.<pub-id pub-id-type="pmid">22407615</pub-id></mixed-citation>
    </ref>
    <ref id="ref10">
      <label>10.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Smit</surname><given-names>A.B.</given-names></name>, <name name-style="western"><surname>Brejc</surname><given-names>K.</given-names></name>, <name name-style="western"><surname>Syed</surname><given-names>N.</given-names></name><etal>etÂ al.</etal></person-group> (<year>2003</year>) <article-title>Structure and function of AChBP, homologue of the ligand-binding domain of the nicotinic acetylcholine receptor</article-title>. <source>Ann. N. Y. Acad. Sci.</source>, <volume>998</volume>, <fpage>81</fpage>â<lpage>92</lpage>.<pub-id pub-id-type="pmid">14592865</pub-id></mixed-citation>
    </ref>
    <ref id="ref11">
      <label>11.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Celie</surname><given-names>P.H.N.</given-names></name>, <name name-style="western"><surname>Kasheverov</surname><given-names>I.E.</given-names></name>, <name name-style="western"><surname>Mordvintsev</surname><given-names>D.Y.</given-names></name><etal>etÂ al.</etal></person-group> (<year>2005</year>) <article-title>Crystal structure of nicotinic acetylcholine receptor homolog Achbp in complex with an Î-conotoxin Pnia variant</article-title>. <source>Nat. Struct. Mol. Biol.</source>, <volume>12</volume>, <fpage>582</fpage>â<lpage>588</lpage>.<pub-id pub-id-type="pmid">15951818</pub-id></mixed-citation>
    </ref>
    <ref id="ref12">
      <label>12.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Xu</surname><given-names>M.</given-names></name>, <name name-style="western"><surname>Zhu</surname><given-names>X.</given-names></name>, <name name-style="western"><surname>Yu</surname><given-names>J.</given-names></name><etal>etÂ al.</etal></person-group> (<year>2017</year>) <article-title>The crystal structure of Ac-AChBP in complex with Î±-conotoxin LvIA reveals the mechanism of its selectivity towards different nAChR subtypes</article-title>. <source>Protein Cell</source>, <volume>8</volume>, <fpage>675</fpage>â<lpage>685</lpage>.<pub-id pub-id-type="pmid">28585176</pub-id></mixed-citation>
    </ref>
    <ref id="ref13">
      <label>13.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ulens</surname><given-names>C.</given-names></name>, <name name-style="western"><surname>Hogg</surname><given-names>R.C.</given-names></name>, <name name-style="western"><surname>Celie</surname><given-names>P.H.</given-names></name><etal>etÂ al.</etal></person-group> (<year>2006</year>) <article-title>Structural determinants of selective Î±-conotoxin binding to a nicotinic acetylcholine receptor homolog AChBP</article-title>. <source>Proc. Natl. Acad. Sci. USA</source>, <volume>103</volume>, <fpage>3615</fpage>â<lpage>3620</lpage>.<pub-id pub-id-type="pmid">16505382</pub-id></mixed-citation>
    </ref>
    <ref id="ref14">
      <label>14.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Abraham</surname><given-names>N.</given-names></name>, <name name-style="western"><surname>Healy</surname><given-names>M.</given-names></name>, <name name-style="western"><surname>Ragnarsson</surname><given-names>L.</given-names></name><etal>etÂ al.</etal></person-group> (<year>2017</year>) <article-title>Structural mechanisms for Î±-conotoxin activity at the human Î±3Î²4 nicotinic acetylcholine receptor</article-title>. <source>Sci. Rep.</source>, <volume>7</volume>, <fpage>45466</fpage>.<pub-id pub-id-type="pmid">28361878</pub-id></mixed-citation>
    </ref>
    <ref id="ref15">
      <label>15.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Lin</surname><given-names>B.</given-names></name>, <name name-style="western"><surname>Xu</surname><given-names>M.</given-names></name>, <name name-style="western"><surname>Zhu</surname><given-names>X.</given-names></name><etal>etÂ al.</etal></person-group> (<year>2016</year>) <article-title>From crystal structure of Î±-conotoxin GIC in complex with Ac-AChBP to molecular determinants of its high selectivity for Î±3Î²2 nAChR</article-title>. <source>Sci. Rep.</source>, <volume>6</volume>, <fpage>22349</fpage>.<pub-id pub-id-type="pmid">26925840</pub-id></mixed-citation>
    </ref>
    <ref id="ref16">
      <label>16.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Hansen</surname><given-names>S.B.</given-names></name>, <name name-style="western"><surname>Sulzenbacher</surname><given-names>G.</given-names></name>, <name name-style="western"><surname>Huxford</surname><given-names>T.</given-names></name><etal>etÂ al.</etal></person-group> (<year>2005</year>) <article-title>Structures of Aplysia AChBP complexes with nicotinic agonists and antagonists reveal distinctive binding interfaces and conformations</article-title>. <source>EMBO J.</source>, <volume>24</volume>, <fpage>3635</fpage>â<lpage>3646</lpage>.<pub-id pub-id-type="pmid">16193063</pub-id></mixed-citation>
    </ref>
    <ref id="ref17">
      <label>17.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Dutertre</surname><given-names>S.</given-names></name>, <name name-style="western"><surname>Ulens</surname><given-names>C.</given-names></name>, <name name-style="western"><surname>BÃ¼ttner</surname><given-names>R.</given-names></name><etal>etÂ al.</etal></person-group> (<year>2007</year>) <article-title>AChBP-targeted Î±-conotoxin correlates distinct binding orientations with nAChR subtype selectivity</article-title>. <source>EMBO J.</source>, <volume>26</volume>, <fpage>3858</fpage>â<lpage>3867</lpage>.<pub-id pub-id-type="pmid">17660751</pub-id></mixed-citation>
    </ref>
    <ref id="ref18">
      <label>18.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Wisedchaisri</surname><given-names>G.</given-names></name>, <name name-style="western"><surname>Tonggu</surname><given-names>L.</given-names></name>, <name name-style="western"><surname>McCord</surname><given-names>E.</given-names></name><etal>etÂ al.</etal></person-group> (<year>2019</year>) <article-title>Resting-state structure and gating mechanism of a voltage-gated sodium channel</article-title>. <source>Cell</source>, <volume>178</volume>, <fpage>993</fpage>â<lpage>1003</lpage>.<pub-id pub-id-type="pmid">31353218</pub-id></mixed-citation>
    </ref>
    <ref id="ref19">
      <label>19.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Payandeh</surname><given-names>J.</given-names></name>, <name name-style="western"><surname>Scheuer</surname><given-names>T.</given-names></name>, <name name-style="western"><surname>Zheng</surname><given-names>N.</given-names></name><etal>etÂ al.</etal></person-group> (<year>2011</year>) <article-title>The crystal structure of a voltage-gated sodium channel</article-title>. <source>Nature</source>, <volume>475</volume>, <fpage>353</fpage>â<lpage>358</lpage>.<pub-id pub-id-type="pmid">21743477</pub-id></mixed-citation>
    </ref>
    <ref id="ref20">
      <label>20.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>BagnÃ©ris</surname><given-names>C.</given-names></name>, <name name-style="western"><surname>DeCaen</surname><given-names>P.G.</given-names></name>, <name name-style="western"><surname>Naylor</surname><given-names>C.E.</given-names></name><etal>etÂ al.</etal></person-group> (<year>2014</year>) <article-title>Prokaryotic NavMs channel as a structural and functional model for eukaryotic sodium channel antagonism</article-title>. <source>Proc. Natl. Acad. Sci. USA</source>, <volume>111</volume>, <fpage>8428</fpage>â<lpage>8433</lpage>.<pub-id pub-id-type="pmid">24850863</pub-id></mixed-citation>
    </ref>
    <ref id="ref21">
      <label>21.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Pan</surname><given-names>X.</given-names></name>, <name name-style="western"><surname>Li</surname><given-names>Z.</given-names></name>, <name name-style="western"><surname>Huang</surname><given-names>X.</given-names></name><etal>etÂ al.</etal></person-group> (<year>2019</year>) <article-title>Molecular basis for pore blockade of human Na<sup>+</sup> channel Nav1.2 by the Î¼-conotoxin KIIIA</article-title>. <source>Science</source>, <volume>363</volume>, <fpage>1309</fpage>â<lpage>1313</lpage>.<pub-id pub-id-type="pmid">30765605</pub-id></mixed-citation>
    </ref>
    <ref id="ref22">
      <label>22.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Patel</surname><given-names>D.</given-names></name>, <name name-style="western"><surname>Mahdavi</surname><given-names>S.</given-names></name> and <name name-style="western"><surname>Kuyucak</surname><given-names>S.</given-names></name></person-group> (<year>2016</year>) <article-title>Computational study of binding of Î¼-conotoxin GIIIA to bacterial sodium channels NaVAb and NaVRh</article-title>. <source>Biochemistry</source>, <volume>55</volume>, <fpage>1929</fpage>â<lpage>1938</lpage>.<pub-id pub-id-type="pmid">26959170</pub-id></mixed-citation>
    </ref>
    <ref id="ref23">
      <label>23.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Berman</surname><given-names>H.M.</given-names></name>, <name name-style="western"><surname>Westbrook</surname><given-names>J.</given-names></name>, <name name-style="western"><surname>Feng</surname><given-names>Z.</given-names></name><etal>etÂ al.</etal></person-group> (<year>2000</year>) <article-title>The Protein Data Bank</article-title>. <source>Nucleic Acids Res.</source>, <volume>28</volume>, <fpage>235</fpage>â<lpage>242</lpage>.<pub-id pub-id-type="pmid">10592235</pub-id></mixed-citation>
    </ref>
    <ref id="ref24">
      <label>24.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Gharpure</surname><given-names>A.</given-names></name>, <name name-style="western"><surname>Teng</surname><given-names>J.</given-names></name>, <name name-style="western"><surname>Zhuang</surname><given-names>Y.</given-names></name><etal>etÂ al.</etal></person-group> (<year>2019</year>) <article-title>Agonist selectivity and ion permeation in the Î±3Î²4 ganglionic nicotinic receptor</article-title>. <source>Neuron</source>, <volume>104</volume>, <fpage>501</fpage>â<lpage>511</lpage>.<pub-id pub-id-type="pmid">31488329</pub-id></mixed-citation>
    </ref>
    <ref id="ref25">
      <label>25.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Walsh</surname><given-names>R.M.</given-names><suffix>Jr.</suffix></name>, <name name-style="western"><surname>Roh</surname><given-names>S.H.</given-names></name>, <name name-style="western"><surname>Gharpure</surname><given-names>A.</given-names></name><etal>etÂ al.</etal></person-group> (<year>2018</year>) <article-title>Structural principles of distinct assemblies of the human Î±4Î²2 nicotinic receptor</article-title>. <source>Nature</source>, <volume>557</volume>, <fpage>261</fpage>â<lpage>265</lpage>.<pub-id pub-id-type="pmid">29720657</pub-id></mixed-citation>
    </ref>
    <ref id="ref26">
      <label>26.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Shen</surname><given-names>H.</given-names></name>, <name name-style="western"><surname>Zhou</surname><given-names>Q.</given-names></name>, <name name-style="western"><surname>Pan</surname><given-names>X.</given-names></name><etal>etÂ al.</etal></person-group> (<year>2017</year>) <article-title>Structure of a eukaryotic voltage-gated sodium channel at near-atomic resolution</article-title>. <source>Science</source>, <volume>355</volume>, <fpage>6328</fpage>.</mixed-citation>
    </ref>
    <ref id="ref27">
      <label>27.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Cheng</surname><given-names>H.</given-names></name>, <name name-style="western"><surname>Fan</surname><given-names>C.</given-names></name> and <name name-style="western"><surname>Zhang</surname><given-names>S.W.</given-names></name></person-group> (<year>2015</year>) <article-title>Crystallization scale purification of Î±7 nicotinic acetylcholine receptor from mammalian cells using a BacMam expression system</article-title>. <source>Acta Pharmacol. Sin.</source>, <volume>36</volume>, <fpage>1013</fpage>â<lpage>1023</lpage>.<pub-id pub-id-type="pmid">26073323</pub-id></mixed-citation>
    </ref>
    <ref id="ref28">
      <label>28.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Burley</surname><given-names>S.K.</given-names></name>, <name name-style="western"><surname>Berman</surname><given-names>H.M.</given-names></name>, <name name-style="western"><surname>Kleywegt</surname><given-names>G.J.</given-names></name><etal>etÂ al.</etal></person-group> (<year>2017</year>) <article-title>Protein Data Bank PDB: the single global macromolecular structure archive</article-title>. <source>Methods Mol. Biol.</source>, <volume>1607</volume>, <fpage>627</fpage>â<lpage>641</lpage>.<pub-id pub-id-type="pmid">28573592</pub-id></mixed-citation>
    </ref>
    <ref id="ref29">
      <label>29.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Mansbach</surname><given-names>R.A.</given-names></name>, <name name-style="western"><surname>Travers</surname><given-names>T.</given-names></name>, <name name-style="western"><surname>McMahon</surname><given-names>B.H.</given-names></name><etal>etÂ al.</etal></person-group> (<year>2019</year>) <article-title>Snails in silico: a review of computational studies on the conopeptides</article-title>. <source>Mar. Drugs</source>, <volume>17</volume>, <fpage>pii: E145</fpage>.</mixed-citation>
    </ref>
    <ref id="ref30">
      <label>30.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Rashid</surname><given-names>M.H.</given-names></name>, <name name-style="western"><surname>Mahdavi</surname><given-names>S.</given-names></name> and <name name-style="western"><surname>Kuyucak</surname><given-names>S.</given-names></name></person-group> (<year>2013</year>) <article-title>Computational studies of marine toxins targeting ion channels</article-title>. <source>Mar. Drugs</source>, <volume>11</volume>, <fpage>848</fpage>â<lpage>869</lpage>.<pub-id pub-id-type="pmid">23528952</pub-id></mixed-citation>
    </ref>
    <ref id="ref31">
      <label>31.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Mahdavi</surname><given-names>S.</given-names></name> and <name name-style="western"><surname>Kuyucak</surname><given-names>S.</given-names></name></person-group> (<year>2014</year>) <article-title>Systematic study of binding of Î¼-conotoxins to the sodium channel NaV1.4</article-title>. <source>Toxins (Basel)</source>, <volume>6</volume>, <fpage>3454</fpage>â<lpage>3470</lpage>.<pub-id pub-id-type="pmid">25529306</pub-id></mixed-citation>
    </ref>
    <ref id="ref32">
      <label>32.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Dutertre</surname><given-names>S.</given-names></name>, <name name-style="western"><surname>Nicke</surname><given-names>A.</given-names></name>, <name name-style="western"><surname>Tyndall</surname><given-names>J.D.</given-names></name><etal>etÂ al.</etal></person-group> (<year>2004</year>) <article-title>Determination of Î±-conotoxin binding modes on neuronal nicotinic acetylcholine receptors</article-title>. <source>J. Mol. Recognit.</source>, <volume>17</volume>, <fpage>339</fpage>â<lpage>347</lpage>.<pub-id pub-id-type="pmid">15227641</pub-id></mixed-citation>
    </ref>
    <ref id="ref33">
      <label>33.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Tabassum</surname><given-names>N.</given-names></name>, <name name-style="western"><surname>Tae</surname><given-names>H.S.</given-names></name>, <name name-style="western"><surname>Jia</surname><given-names>X.</given-names></name><etal>etÂ al.</etal></person-group> (<year>2017</year>) <article-title>Role of CysI-CysIII disulfide bond on the structure and activity of Î±-conotoxins at human neuronal nicotinic acetylcholine receptors</article-title>. <source>ACS Omega</source>, <volume>2</volume>, <fpage>4621</fpage>â<lpage>4631</lpage>.<pub-id pub-id-type="pmid">30023726</pub-id></mixed-citation>
    </ref>
    <ref id="ref34">
      <label>34.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Chen</surname><given-names>F.</given-names></name>, <name name-style="western"><surname>Huang</surname><given-names>W.</given-names></name>, <name name-style="western"><surname>Jiang</surname><given-names>T.</given-names></name><etal>etÂ al.</etal></person-group> (<year>2018</year>) <article-title>Determination of the Î¼-conotoxin PIIIA specificity against voltage-gated sodium channels from binding energy calculations</article-title>. <source>Mar. Drugs</source>, <volume>16</volume>, <fpage>pii: E153</fpage>.</mixed-citation>
    </ref>
    <ref id="ref35">
      <label>35.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Yu</surname><given-names>R.</given-names></name>, <name name-style="western"><surname>Tae</surname><given-names>H.S.</given-names></name>, <name name-style="western"><surname>Tabassum</surname><given-names>N.</given-names></name><etal>etÂ al.</etal></person-group> (<year>2018</year>) <article-title>Molecular determinants conferring the stoichiometric-dependent activity of Î±-conotoxins at the human Î±9Î±10 nicotinic acetylcholine receptor subtype</article-title>. <source>J. Med. Chem.</source>, <volume>61</volume>, <fpage>4628</fpage>â<lpage>4634</lpage>.<pub-id pub-id-type="pmid">29733583</pub-id></mixed-citation>
    </ref>
    <ref id="ref36">
      <label>36.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Xu</surname><given-names>X.</given-names></name>, <name name-style="western"><surname>Liang</surname><given-names>J.</given-names></name>, <name name-style="western"><surname>Zhang</surname><given-names>Z.</given-names></name><etal>etÂ al.</etal></person-group> (<year>2019</year>) <article-title>Blockade of human Î±7 nicotinic acetylcholine receptor by Î±-conotoxin ImI dendrimer: insight from computational simulations</article-title>. <source>Mar. Drugs</source>, <volume>17</volume>, <fpage>pii: E303</fpage>.</mixed-citation>
    </ref>
    <ref id="ref37">
      <label>37.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Yu</surname><given-names>R.</given-names></name>, <name name-style="western"><surname>Kompella</surname><given-names>S.N.</given-names></name>, <name name-style="western"><surname>Adams</surname><given-names>D.J.</given-names></name><etal>etÂ al.</etal></person-group> (<year>2013</year>) <article-title>Determination of the Î±-conotoxin Vc1.1 binding site on the Î±9Î±10 nicotinic acetylcholine receptor</article-title>. <source>J. Med. Chem.</source>, <volume>56</volume>, <fpage>3557</fpage>â<lpage>3567</lpage>.<pub-id pub-id-type="pmid">23566299</pub-id></mixed-citation>
    </ref>
    <ref id="ref38">
      <label>38.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Yu</surname><given-names>R.</given-names></name>, <name name-style="western"><surname>Craik</surname><given-names>D.J.</given-names></name> and <name name-style="western"><surname>Kaas</surname><given-names>Q.</given-names></name></person-group> (<year>2011</year>) <article-title>Blockade of neuronal Î±7-nAChR by Î±-conotoxin ImI explained by computational scanning and energy calculations</article-title>. <source>PLoS Comput. Biol.</source>, <volume>7</volume>, <fpage>e1002011</fpage>.<pub-id pub-id-type="pmid">21390272</pub-id></mixed-citation>
    </ref>
    <ref id="ref39">
      <label>39.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Chu</surname><given-names>X.</given-names></name>, <name name-style="western"><surname>Tae</surname><given-names>H.S.</given-names></name>, <name name-style="western"><surname>Xu</surname><given-names>Q.</given-names></name><etal>etÂ al.</etal></person-group> (<year>2019</year>) <article-title>Î±-Conotoxin Vc1.1 structure-activity relationship at the human Î±9Î±10 nicotinic acetylcholine receptor investigated by minimal side chain replacement</article-title>. <source>ACS Chem. Nerosci.</source>, <volume>10</volume>, <fpage>4328</fpage>â<lpage>4336</lpage>.</mixed-citation>
    </ref>
    <ref id="ref40">
      <label>40.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Yu</surname><given-names>R.</given-names></name>, <name name-style="western"><surname>Seymour</surname><given-names>V.A.</given-names></name>, <name name-style="western"><surname>Berecki</surname><given-names>G.</given-names></name><etal>etÂ al.</etal></person-group> (<year>2015</year>) <article-title>Less is more: design of a highly stable disulfide-deleted mutant of analgesic cyclic Î±-conotoxin Vc1.1</article-title>. <source>Sci. Rep.</source>, <volume>5</volume>, <fpage>13264</fpage>.<pub-id pub-id-type="pmid">26290113</pub-id></mixed-citation>
    </ref>
  </ref-list>
</back>
